Evidence map›Paper›PMID 42101509›Full record

ReviewMolecular biology reports2026

Curcumin as a ceramide metabolism-targeting agent: Molecular mechanisms and therapeutic implications in cancer.

Sajad Dehnavi, Mahvash Sadeghi, Kianush Charoghdoozi, Prashant Kesharwani, Amirhossein Sahebkar

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sajad DehnaviImmunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahvash SadeghiImmunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Kianush CharoghdooziStudent Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Prashant KesharwaniNext-Generation Translational Nanomedicine Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya (A Central University), Sagar, 470003, Madhya Pradesh, India. prashantdops@gmail.com.
Amirhossein SahebkarApplied Biomedical Research Center, Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran. amir_Saheb2000@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Curcumin, a lipophilic polyphenol widely used in traditional medicine, is the active ingredient in turmeric (Curcuma longa L.). It has various therapeutic effects, such as antitumor potential, due to its interaction with intracellular and extracellular molecules associated with different malignancies. Ceramides are fundamental constituents of cellular membranes that maintain the stability and integrity of cells. Additionally, they have become key signaling agents that govern a spectrum of cellular functions, such as differentiation, proliferation, apoptosis, and cellular senescence. This review primarily introduces ceramides and their metabolism, summarizes their crucial roles in cancer, and categorizes and discusses the mechanisms and pathways through which curcumin could potentially exert its antitumor effects by targeting ceramides. These mechanisms include apoptosis- and autophagy-associated pathways, de novo ceramide generation, and influencing intracellular free calcium levels and acid inhibition. ceramidase, and combinational strategies using various chemical agents, ceramides, or ceramide analogs to enhance curcumin's efficacy. Finally, the review concludes with remarks and prospects for the future of curcumin's antitumor potential in the context of ceramide targeting.

Indexed as

CeramidesCurcuminNeoplasmsAnimalsAntineoplastic AgentsApoptosisAutophagyCell ProliferationHumansSignal TransductionAntineoplastic AgentsCeramidesCurcuminAntitumor potentialApoptosisCeramideCurcuminMedicine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.